arrow_back Back Filing freshness 10-Q Q1 FY2023 SEC EDGAR

download Export Data

Bioquest Corp

BQST

— Price unavailable

22 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

Bioquest Corp shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 7.3% ↘

FCF / Share $-0.00

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-123.43K

↑ +71.8% —

FCF / Share Free cash flow per share

$-0.00

↑ +77.0% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

100

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q3 FY2020 Jan 31, 2014 10-Q ↗	Q2 FY2020 Oct 31, 2013 10-Q ↗	Q1 FY2020 Apr 30, 2014 10-Q ↗	Q4 FY2019 Apr 30, 2013 10-K ↗	Q3 FY2019 Jan 31, 2013 10-Q ↗	Q2 FY2019 Oct 31, 2012 10-Q ↗	Q1 FY2019 Apr 30, 2013 10-Q ↗	Q4 FY2018 Apr 30, 2012 10-K ↗	Q1 FY2018 May 16, 2011 10-Q ↗	Q3 FY2015 Jan 31, 2015 10-Q ↗	Q2 FY2015 Oct 31, 2014 10-Q ↗	Q1 FY2015 Jul 31, 2014 10-Q ↗
EPS Growth YoY (%)	80.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	74.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	75.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	71.8% Excellent ↑ Excellent Improving Year-over-year change in net income	65.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-35.6% Weak ↑ Weak Improving Year-over-year change in net income	-35.6% Weak ↑ Weak Improving Year-over-year change in net income	-35.6% Weak ↑ Weak Improving Year-over-year change in net income	-424.0% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-9802.6% Weak ↓ Weak Declining Year-over-year change in net income	-6288.4% Weak ↓ Weak Declining Year-over-year change in net income	-5569.9% Weak ↓ Weak Declining Year-over-year change in net income	N/M	0.6% Caution Caution Year-over-year change in net income	-1847.5% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	77.0% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	—	98.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	96.5% Excellent Excellent Year-over-year change in free cash flow	41.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q3 FY2020 Jan 31, 2014 10-Q ↗	Q2 FY2020 Oct 31, 2013 10-Q ↗	Q1 FY2020 Apr 30, 2014 10-Q ↗	Q4 FY2019 Apr 30, 2013 10-K ↗	Q3 FY2019 Jan 31, 2013 10-Q ↗	Q2 FY2019 Oct 31, 2012 10-Q ↗	Q1 FY2019 Apr 30, 2013 10-Q ↗	Q4 FY2018 Apr 30, 2012 10-K ↗	Q1 FY2018 May 16, 2011 10-Q ↗	Q3 FY2015 Jan 31, 2015 10-Q ↗	Q2 FY2015 Oct 31, 2014 10-Q ↗	Q1 FY2015 Jul 31, 2014 10-Q ↗
FCF / Net Income (x)	0.15x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.21x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q3 FY2020 Jan 31, 2014 10-Q ↗	Q2 FY2020 Oct 31, 2013 10-Q ↗	Q1 FY2020 Apr 30, 2014 10-Q ↗	Q4 FY2019 Apr 30, 2013 10-K ↗	Q3 FY2019 Jan 31, 2013 10-Q ↗	Q2 FY2019 Oct 31, 2012 10-Q ↗	Q1 FY2019 Apr 30, 2013 10-Q ↗	Q4 FY2018 Apr 30, 2012 10-K ↗	Q1 FY2018 May 16, 2011 10-Q ↗	Q3 FY2015 Jan 31, 2015 10-Q ↗	Q2 FY2015 Oct 31, 2014 10-Q ↗	Q1 FY2015 Jul 31, 2014 10-Q ↗
Return on Invested Capital (%)	7.3% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	41.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	31.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	17.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	30.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	76.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-20.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	-2.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	-14.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-15.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-332.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-685.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	45449.1% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-2576.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3274.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4007.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-80452.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-26.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-2.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-16.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-18.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	23.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+53%)	56.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+279%)	111.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+640%)	98.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+557%)	20.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+36%)	39.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+165%)	—	—	—	97.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+546%)	—	—	-0.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-104%)	-26.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-275%)	—	—	-2.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-119%)	—	—	-17.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-218%)	-19.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	-34.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-329%)

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q3 FY2020 Jan 31, 2014 10-Q ↗	Q2 FY2020 Oct 31, 2013 10-Q ↗	Q1 FY2020 Apr 30, 2014 10-Q ↗	Q4 FY2019 Apr 30, 2013 10-K ↗	Q3 FY2019 Jan 31, 2013 10-Q ↗	Q2 FY2019 Oct 31, 2012 10-Q ↗	Q1 FY2019 Apr 30, 2013 10-Q ↗	Q4 FY2018 Apr 30, 2012 10-K ↗	Q1 FY2018 May 16, 2011 10-Q ↗	Q3 FY2015 Jan 31, 2015 10-Q ↗	Q2 FY2015 Oct 31, 2014 10-Q ↗	Q1 FY2015 Jul 31, 2014 10-Q ↗
Interest Coverage (x)	-2.09x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	12.87x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-13.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-33.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-567.85x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-536.05x Weak Weak Operating income divided by interest expense Optimal: > 5x	-161.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-14.96K	$-33.54K	$-116.00	$-818.00	$-2.74K	$-260.00	—	—	—	$-166.00	—	—	$-3.10K	$-7.98K	—	—	$-946.00	$-946.00	$0.00	$-310.94K	$-401.19K	$-848.04K

📊 What does each share earn? 6 metrics

Metric	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q3 FY2020 Jan 31, 2014 10-Q ↗	Q2 FY2020 Oct 31, 2013 10-Q ↗	Q1 FY2020 Apr 30, 2014 10-Q ↗	Q4 FY2019 Apr 30, 2013 10-K ↗	Q3 FY2019 Jan 31, 2013 10-Q ↗	Q2 FY2019 Oct 31, 2012 10-Q ↗	Q1 FY2019 Apr 30, 2013 10-Q ↗	Q4 FY2018 Apr 30, 2012 10-K ↗	Q1 FY2018 May 16, 2011 10-Q ↗	Q3 FY2015 Jan 31, 2015 10-Q ↗	Q2 FY2015 Oct 31, 2014 10-Q ↗	Q1 FY2015 Jul 31, 2014 10-Q ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.01	$-0.02	$0.00	$-0.02	$-0.05	$-0.08	$-0.08	$-0.08	$-0.04	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.00	—	$-0.00	$-0.00	$-0.01	—	$-0.01	$-0.01	$-0.01	—	—	—	—	—	$-0.00	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.05	$-0.04	$-0.03	$-0.04	$-0.24	$-0.20	—	—	—	$-0.02	—	—	$0.02	$0.00	—	—	$0.00	—	—	$0.03	$0.03	$0.08
Tangible Book Value per Share (USD)	$-0.05	$-0.04	$-0.03	$-0.04	$-0.24	$-0.20	—	—	—	$-0.02	—	—	$0.02	$0.00	—	—	$0.00	—	—	$0.01	$0.01	$0.02
Basic Weighted Avg Shares (shares)	11.34M	—	11.31M	9.42M	8.76M	—	8.35M	8.18M	8.06M	—	—	—	—	—	46.05M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q3 FY2020 Jan 31, 2014 10-Q ↗	Q2 FY2020 Oct 31, 2013 10-Q ↗	Q1 FY2020 Apr 30, 2014 10-Q ↗	Q4 FY2019 Apr 30, 2013 10-K ↗	Q3 FY2019 Jan 31, 2013 10-Q ↗	Q2 FY2019 Oct 31, 2012 10-Q ↗	Q1 FY2019 Apr 30, 2013 10-Q ↗	Q4 FY2018 Apr 30, 2012 10-K ↗	Q1 FY2018 May 16, 2011 10-Q ↗	Q3 FY2015 Jan 31, 2015 10-Q ↗	Q2 FY2015 Oct 31, 2014 10-Q ↗	Q1 FY2015 Jul 31, 2014 10-Q ↗
Working Capital (USD)	$-536.42K	$-432.99K	$-393.56K	$-443.65K	$-2.14M	$-1.77M	—	—	—	$-98.58K	—	—	$875.20K	$7.88K	—	—	—	—	—	$1.55M	$1.08M	$955.11K
Total Equity (USD)	$-536.42K	$-432.99K	$-393.56K	$-443.65K	$-2.14M	$-1.77M	—	—	—	$-138.58K	—	—	$875.20K	$9.02K	—	—	$9.02K	$2.74K	—	$5.08M	$4.63M	$4.77M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2023 Jul 31, 2022 10-Q ↗	Q4 FY2022 Apr 30, 2022 10-K ↗	Q3 FY2022 Jan 31, 2022 10-Q ↗	Q2 FY2022 Oct 31, 2021 10-Q ↗	Q1 FY2022 Jul 31, 2021 10-Q ↗	Q4 FY2021 Apr 30, 2021 10-K ↗	Q3 FY2021 Jan 31, 2021 10-Q ↗	Q2 FY2021 Oct 31, 2020 10-Q ↗	Q1 FY2021 Jul 31, 2020 10-Q ↗	Q4 FY2020 Apr 30, 2020 10-K ↗	Q3 FY2020 Jan 31, 2014 10-Q ↗	Q2 FY2020 Oct 31, 2013 10-Q ↗	Q1 FY2020 Apr 30, 2014 10-Q ↗	Q4 FY2019 Apr 30, 2013 10-K ↗	Q3 FY2019 Jan 31, 2013 10-Q ↗	Q2 FY2019 Oct 31, 2012 10-Q ↗	Q1 FY2019 Apr 30, 2013 10-Q ↗	Q4 FY2018 Apr 30, 2012 10-K ↗	Q1 FY2018 May 16, 2011 10-Q ↗	Q3 FY2015 Jan 31, 2015 10-Q ↗	Q2 FY2015 Oct 31, 2014 10-Q ↗	Q1 FY2015 Jul 31, 2014 10-Q ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	$1.15K	$29.82K	$0.00
Depreciation Expense (USD)	—	—	—	—	—	—	—	—	—	—	$162.00	$162.00	$162.00	$648.00	$162.00	$-162.00	$162.00	—	—	$3.07K	$2.63K	$0.00
Net Income, GAAP (USD)	$-123.43K	$-246.13K	$-437.05K	$-437.05K	$-437.05K	$-704.16K	$-322.23K	$-322.23K	$-322.23K	$-134.38K	$286.00	$-3.25K	$-5.04K	$-2.37K	$-2.38K	$-3.27K	$-259.00	—	—	$-900.18K	$-892.23K	$-1.64M
Operating Cash Flow (USD)	$-18.59K	$-51.58K	$-702.00	$-1.92K	$-62.52K	$-5.10K	$-43.01K	$-47.57K	$-97.52K	$-39.56K	—	—	—	—	$-2.21K	$-3.11K	$-97.00	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 22 quarters

Bioquest Corp

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BQST with peers